Alkem Laboratories Financials
NSE: ALKEM | BSE: 539523
₹5,190.00
As on 04-Sep-2026 15:57IST
Market cap
₹62,078 Cr
Revenue (TTM)
₹15,081 Cr
P/E Ratio
28.8
P/B Ratio
4.3
Div. Yield
1 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
15,081.28
|
14,712.27
|
12,964.52
|
12,667.58
|
11,599.26
|
10,634.19
|
|||||
|
Total Income
|
15,680.89
|
15,306.53
|
13,458.26
|
12,978.42
|
11,815.34
|
10,796.84
|
|||||
|
Total Expenditure
|
12,049.07
|
11,717.97
|
10,452.37
|
10,422.09
|
9,989.81
|
8,581.27
|
|||||
|
EBITDA
|
3,032.21
|
2,994.30
|
2,512.15
|
2,245.49
|
1,609.45
|
2,052.92
|
|||||
|
Depreciation
|
394.57
|
382.06
|
357.16
|
299.30
|
310.42
|
303.96
|
|||||
|
EBIT
|
2,637.64
|
2,612.24
|
2,154.99
|
1,946.19
|
1,299.03
|
1,748.96
|
|||||
|
Interest
|
177.62
|
160.78
|
121.70
|
112.41
|
107.36
|
52.37
|
|||||
|
Other Income
|
599.61
|
594.26
|
493.74
|
310.84
|
216.08
|
162.65
|
|||||
|
Exceptional Items
|
-187.76
|
-174.83
|
--
|
-121.49
|
-102.98
|
-14.96
|
|||||
|
Profit before Tax
|
2,871.87
|
2,870.89
|
2,527.03
|
2,023.13
|
1,304.77
|
1,844.28
|
|||||
|
Provision for Tax
|
665.57
|
517.76
|
311.03
|
211.67
|
297.96
|
163.96
|
|||||
|
Profit after Tax
|
2,206.30
|
2,353.13
|
2,216.00
|
1,811.46
|
1,006.81
|
1,680.32
|
|||||
|
Minority Interest
|
-46.73
|
-49.36
|
-49.90
|
-15.69
|
-22.64
|
-34.70
|
|||||
|
Share of Associate
|
-2.07
|
-1.97
|
-0.62
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
2,157.50
|
2,301.80
|
2,165.48
|
1,795.77
|
984.17
|
1,645.62
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
13,820.10
|
13,820.10
|
11,984.87
|
10,312.06
|
9,045.29
|
8,637.90
|
|||||
|
Minority Interest
|
-46.73
|
528.83
|
448.76
|
402.34
|
389.71
|
209.43
|
|||||
|
Non-Current Liabilities
|
1,741.34
|
-78.01
|
-447.74
|
-648.88
|
-688.00
|
-892.74
|
|||||
|
Current Liabilities
|
4,782.70
|
4,782.70
|
3,960.67
|
3,994.55
|
3,707.15
|
4,805.34
|
|||||
|
Total Liabilities
|
20,872.97
|
20,857.85
|
17,691.10
|
15,574.90
|
13,756.65
|
14,069.19
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
6,708.01
|
6,843.10
|
5,007.03
|
3,648.49
|
3,724.47
|
4,324.50
|
|||||
|
Current Assets
|
12,210.52
|
12,210.52
|
10,811.19
|
10,411.58
|
8,606.42
|
8,433.70
|
|||||
|
Total Assets
|
20,872.97
|
20,857.85
|
17,691.10
|
15,574.90
|
13,756.65
|
14,069.19
|
|||||
|
Total Debt*
|
--
|
1,623.50
|
1,062.79
|
1,213.97
|
1,307.15
|
2,580.12
|
|||||
|
Net Current Assets
|
7,427.82
|
7,427.82
|
6,850.52
|
6,417.03
|
4,899.27
|
3,628.36
|
|||||
|
Contingent Liabilities
|
--
|
1,113.14
|
881.05
|
91.71
|
284.57
|
268.63
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,963.03
|
1,912.84
|
1,948.07
|
1,682.50
|
1,111.02
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-1,667.21
|
-1,298.76
|
-1,008.50
|
112.84
|
-1,435.13
|
|||||
|
Cash from Financing Activities
|
--
|
-503.40
|
-810.99
|
-1,145.01
|
-1,760.82
|
379.57
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-207.58
|
-196.91
|
-205.44
|
34.52
|
55.46
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
190.35
|
192.54
|
181.14
|
150.21
|
82.32
|
137.65
|
|||||
|
Cash EPS (₹)
|
180.45
|
228.79
|
215.24
|
176.56
|
110.18
|
165.98
|
|||||
|
Adjusted Book Value (₹)
|
1,196.51
|
1,153.04
|
999.47
|
860.94
|
756.56
|
722.48
|
|||||
|
Dividend per Share (₹)
|
1.02
|
53.00
|
45.00
|
40.00
|
50.00
|
34.00
|
|||||
|
Cash Flow per Share (₹)
|
--
|
164.20
|
160.00
|
162.95
|
140.74
|
92.93
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
142.43
|
140.83
|
150.55
|
118.03
|
92.05
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
21.28
|
21.56
|
19.52
|
13.09
|
18.69
|
|||||
|
ROE (%)
|
16.76
|
18.29
|
19.93
|
18.74
|
11.39
|
20.99
|
|||||
|
ROA (%)
|
11.44
|
13.44
|
14.77
|
13.66
|
7.99
|
14.50
|
|||||
|
EBIT Margin (%)
|
17.49
|
17.76
|
16.62
|
15.36
|
11.20
|
16.45
|
|||||
|
Net Margin (%)
|
14.07
|
15.37
|
16.47
|
13.96
|
8.52
|
15.56
|
|||||
|
Cash Profit Margin (%)
|
--
|
12.12
|
13.33
|
10.89
|
7.34
|
12.99
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
13.36
|
13.48
|
2.34
|
9.21
|
9.08
|
19.96
|
|||||
|
EBIT Growth (%)
|
15.78
|
21.22
|
10.73
|
49.82
|
-25.73
|
4.87
|
|||||
|
Net Profit Growth (%)
|
0.11
|
6.19
|
22.33
|
79.92
|
-40.08
|
3.87
|
|||||
|
EPS Growth (%)
|
-5.56
|
6.30
|
20.59
|
82.47
|
-40.19
|
3.82
|
|||||
|
Book Value Growth (%)
|
--
|
15.36
|
16.09
|
13.80
|
4.72
|
17.11
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
28.77
|
27.54
|
26.94
|
32.89
|
41.27
|
26.28
|
|||||
|
Price / Book Value
|
4.34
|
4.60
|
4.88
|
5.74
|
4.49
|
5.01
|
|||||
|
Dividend Yield (%)
|
1.02
|
1.00
|
0.92
|
0.81
|
1.47
|
0.94
|
|||||
|
EV/EBITDA
|
17.06
|
17.64
|
19.24
|
22.96
|
21.53
|
19.52
|
|||||
|
Close Price (₹)
|
5,570.00
|
5,299.00
|
4,881.70
|
4,942.00
|
3,396.10
|
3,620.70
|
|||||
|
High Price (₹)
|
5,933.50
|
5,933.50
|
6,440.00
|
5,520.00
|
3,625.20
|
4,070.00
|
|||||
|
Low Price (₹)
|
4,716.20
|
4,611.85
|
4,407.05
|
3,186.30
|
2,828.00
|
2,670.10
|
|||||
|
Market Cap (₹ Cr)
|
62,078.15
|
63,401.06
|
58,340.34
|
59,060.06
|
40,621.77
|
43,242.43
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.04
|
0.12
|
0.09
|
0.12
|
0.14
|
0.30
|
|||||
|
Short term debt to equity ratio
|
--
|
0.08
|
0.06
|
0.11
|
0.14
|
0.30
|
|||||
|
Current Ratio
|
2.55
|
2.55
|
2.73
|
2.61
|
2.32
|
1.76
|
|||||
|
Quick Ratio
|
1.86
|
1.86
|
1.99
|
1.94
|
1.62
|
1.13
|
|||||
|
Interest Coverage
|
17.17
|
18.86
|
21.76
|
19.00
|
13.15
|
36.22
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
19.75
|
20.25
|
19.02
|
17.78
|
18.38
|
17.72
|
|||||
|
Asset Turnover
|
0.78
|
1.29
|
1.29
|
1.46
|
1.42
|
1.32
|
|||||
|
Receivable days
|
--
|
44.04
|
44.62
|
41.28
|
40.86
|
41.72
|
|||||
|
Inventory Days
|
--
|
50.59
|
52.79
|
49.60
|
57.10
|
63.54
|
|||||
|
Payable days
|
--
|
167.84
|
163.20
|
122.87
|
97.40
|
114.79
|
|||||
|
Cash Conversion Cycle
|
--
|
-73.22
|
-65.80
|
-31.98
|
0.57
|
-9.53
|